Toxicity Clinical Trial
Official title:
In Vivo Comparison of Genotoxic and Cytotoxic Effects of Different Brands of Toothpaste - Without and With Fluoride
Verified date | October 2017 |
Source | University of Split, School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objectives. Toothpaste contains many potentially harmful ingredients, including some that can
lead to serious long-term health problems. Everyday use of oral health care products has
increased, highlighting the need for healthcare clinicians and consumers to be informed of
the potential benefits and risks associated with these products. The aim of this study is to
evaluate possible DNA damages to oral epithelial cells in participants exposed to toothpaste
containing fluoride as opposed to the effects of non-fluoride toothpaste.
Materials and Methods. Forty volunteers were selected among students of dental medicine and
assigned into two experimental groups. Each group used regular non-fluoride toothpaste for
initial two months, followed by the use of fluoride toothpaste of the same brand for the next
two months. The buccal epithelial cells were sampled at baseline and 30, 60, 90 and 120 days
after the beginning of the research. Chromosomal damages were analyzed by micronucleus assay.
Status | Completed |
Enrollment | 40 |
Est. completion date | July 20, 2016 |
Est. primary completion date | June 15, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - completely healthy (no systemic disorders and diseases) Exclusion Criteria: - consuming two or more alcohol units for three or more times a week - patients with oral lesions - history of malignancy - patients with removable and fixed prosthodontics, orthodontic appliances. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Split, School of Medicine |
Tadin A, Gavic L, Zeravica A, Ugrin K, Galic N, Zeljezic D. Assessment of cytotoxic and genotoxic effects of conventional and whitening kinds of toothpaste on oral mucosa cells. Acta Odontol Scand. 2017 Sep 29:1-7. doi: 10.1080/00016357.2017.1384567. [Epub ahead of print] — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cytogenetic damage | The aim of this study was to assess the number of buccal epithelial cells with cytogenetic defects in participants using commercial toothpaste with and without fluoride of the same manufactures and similar composition. Using the micronucleus assay, the effect of toothpaste on the buccal cells was monitored, depending on the time of the exposure. | four months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02273713 -
The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)
|
Phase 1/Phase 2 | |
Terminated |
NCT00531076 -
Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer
|
Phase 1 | |
Active, not recruiting |
NCT02397434 -
Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
|
N/A | |
Withdrawn |
NCT03342300 -
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02649491 -
Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy
|
N/A | |
Active, not recruiting |
NCT03975452 -
Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer
|
N/A | |
Terminated |
NCT00618917 -
MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02760823 -
Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning
|
Phase 2 | |
Completed |
NCT02864030 -
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
|
Phase 4 | |
Completed |
NCT00890448 -
Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
|
N/A | |
Terminated |
NCT01760356 -
Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients
|
||
Recruiting |
NCT06044623 -
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
|
Phase 3 | |
Completed |
NCT01091766 -
Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine
|
Phase 4 | |
Completed |
NCT05277480 -
Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)
|
Phase 2 | |
Recruiting |
NCT03978949 -
Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)
|
Phase 3 | |
Completed |
NCT03491371 -
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
|
N/A | |
Completed |
NCT02143219 -
Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer
|
Phase 2 | |
Completed |
NCT02054741 -
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
|
N/A | |
Not yet recruiting |
NCT06087718 -
Feasibility of the Maastro Applicator in Rectal Cancer
|
N/A | |
Terminated |
NCT02512809 -
Isoflurane-induced Neuroinflammation in Children With Hydrocephalus
|
Phase 3 |